(0.13%) 5 187.70 points
(0.08%) 38 884 points
(-0.10%) 16 333 points
(-0.10%) $78.30
(0.27%) $2.21
(-0.02%) $2 323.80
(-0.16%) $27.50
(0.15%) $989.90
(0.06%) $0.930
(0.17%) $10.92
(0.07%) $0.800
(0.00%) $91.44
0.84% $ 2.40
Live Chart Being Loaded With Signals
Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States...
Stats | |
---|---|
Volumen de hoy | 14 488.00 |
Volumen promedio | 33 491.00 |
Capitalización de mercado | 10.58M |
EPS | $0 ( 2023-08-29 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -16.00 |
ATR14 | $0.0230 (0.95%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2004-08-24 | Patou Gary | Sell | 2 500 | Stock Options |
2004-08-25 | Patou Gary | Sell | 5 500 | Stock Options |
2004-07-01 | Hennessey Robert J | Sell | 1 500 | Stock Options |
2004-06-29 | Kirby Pamela J | Buy | 9 047 | Stock Options(right to buy) |
2004-06-29 | Kirby Pamela J | Buy | 25 000 | Stock Options(right to buy) |
INSIDER POWER |
---|
0.00 |
Last 92 transactions |
Buy: 380 693 | Sell: 1 344 573 |
Volumen Correlación
Genetic Technologies Ltd Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Genetic Technologies Ltd Correlación - Moneda/Commodity
Genetic Technologies Ltd Finanzas
Annual | 2023 |
Ingresos: | $8.69M |
Beneficio Bruto: | $4.35M (50.09 %) |
EPS: | $-0.120 |
FY | 2023 |
Ingresos: | $8.69M |
Beneficio Bruto: | $4.35M (50.09 %) |
EPS: | $-0.120 |
FY | 2022 |
Ingresos: | $6.79M |
Beneficio Bruto: | $6.47M (95.27 %) |
EPS: | $-0.0773 |
FY | 2021 |
Ingresos: | $120 554 |
Beneficio Bruto: | $-240 473 (-199.47 %) |
EPS: | $-48.00 |
Financial Reports:
No articles found.
Genetic Technologies Ltd
Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecologists and breast cancer risk assessment specialists, such as breast surgeons. In addition, the company offers various cancer risk assessment tests under the GeneType for Colorectal Cancer and GeneType for Breast Cancer brand names; and develops other risk assessment tests across a range of diseases, which include cardiovascular, type 2 diabetes, prostate cancer, and melanoma. Further, it offers genetic testing services, including medical, animal, forensic, and plant testing. The company has research and collaboration agreements with the University of Melbourne, Translational Genomics Research Institute, Memorial Sloan Kettering New York Cambridge University, the Ohio State University, and Shivom. Genetic Technologies Limited was incorporated in 1987 and is headquartered in Fitzroy, Australia.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico